CCL4 and Hepatic fibrosis: In the mouse model of liver fibrosis induced by CCL4, BM-MSCs were injected into the injured liver of mice, which significantly reduced the level of IL-17 and increased the level of IL-10, and alleviated the degree of liver fibrosis [68].